Adili Tsaba
Director Técnico/Científico/I+D en VESSL Therapeutics Ltd. .
Perfil
Adili Tsaba is currently working as the Vice President-Regulatory & Clinical Affairs at VESSL Therapeutics Ltd.
Prior to this, Ms. Tsaba completed an undergraduate degree at Technion-Israel Institute of Technology in 1996.
Ms. Tsaba also pursued graduate studies at Technion-Israel Institute of Technology.
Cargos activos de Adili Tsaba
Empresas | Cargo | Inicio |
---|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Director Técnico/Científico/I+D | 01/01/2001 |
Formación de Adili Tsaba.
Technion-Israel Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Adili Tsaba